Medinice S.A Market Cap ($129.07 Million)
Market Cap & Net Worth: Medinice S.A (ICE)
Medinice S.A market cap. Medinice S.A (WAR:ICE) has a market capitalization of $129.07 Million (zł468.98 Million) as of November 7, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #17984 globally and #127 in its home market, demonstrating a -8.68% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medinice S.A's stock price zł50.50 by its total outstanding shares 9286639 (9.29 Million). Also see cash efficiency ratio of Medinice S.A for how efficiently the company converts equity into cash flow.
Medinice S.A Market Cap History (2018–2026)
Medinice S.A market cap history from 2018 to 2026. Data shows growth from $16.36 Million to $129.07 Million (20.92% CAGR). Check ICE stock price for real-time trading data and today's change.
Medinice S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medinice S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ICE year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
106.04x
Medinice S.A's market cap is 106.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.53x
Medinice S.A's market cap is 0.53 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $16.36 Million | $1.11K | -$1.65 Million | 14736.24x | N/A |
| 2019 | $24.28 Million | $164.39K | -$2.25 Million | 147.70x | N/A |
| 2020 | $44.22 Million | $372.00K | -$3.02 Million | 118.86x | N/A |
| 2021 | $52.14 Million | $288.00K | -$2.88 Million | 181.04x | N/A |
| 2022 | $35.63 Million | $246.00K | -$4.92 Million | 144.83x | N/A |
| 2023 | $25.05 Million | $225.00K | -$5.07 Million | 111.32x | N/A |
| 2024 | $19.94 Million | $188.00K | $37.58 Million | 106.04x | 0.53x |
Competitor Companies of ICE by Market Capitalization
Companies near Medinice S.A in the global market cap rankings as of November 7, 2026. Also see Medinice S.A asset portfolio for a full breakdown of the balance sheet.
Key companies related to Medinice S.A by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Medinice S.A (2018–2026)
Market capitalization of Medinice S.A from 2018 to today. Between 2018 and today, Medinice S.A's market cap moved from $16.36 Million to $ 129.07 Million, with a yearly change of 20.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł129.07 Million | +197.06% |
| 2025 | zł43.45 Million | +117.95% |
| 2024 | zł19.94 Million | -20.41% |
| 2023 | zł25.05 Million | -29.70% |
| 2022 | zł35.63 Million | -31.67% |
| 2021 | zł52.14 Million | +17.92% |
| 2020 | zł44.22 Million | +82.11% |
| 2019 | zł24.28 Million | +48.44% |
| 2018 | zł16.36 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Medinice S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $129.07 Million USD |
| MoneyControl | $129.07 Million USD |
| MarketWatch | $129.07 Million USD |
| marketcap.company | $129.07 Million USD |
| Reuters | $129.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medinice S.A
Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators; CoolCryo, a cardiac cryoablation technol… Read more